PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.24
+0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 137.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.77x
- Price / sales
- 430.45x
- Price / cash flow
- -11.83x
Enterprise value
- Enterprise value
- $90.1M
- EV / sales
- 180.11x
- EV / EBITDA
- -2.71x
- EV / EBIT
- -2.55x
- Market cap
- $215.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026